학술논문
The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study.
Document Type
Article
Source
Subject
*SCHIZOPHRENIA treatment
*ZIPRASIDONE
*METABOLIC syndrome risk factors
*SYSTOLIC blood pressure
*THERAPEUTICS
PHYSIOLOGICAL effects of antipsychotic drugs
*
*
*
*
Language
ISSN
0300-7995
Abstract
The article presents an article titled "The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study." Topics discussed include Prevalence of individual metabolic syndrome risk factors including triglycerides, high-density lipoprotein cholesterol, and systolic blood pressure at week 52, the U.S. National Cholesterol Education Program panel criteria for metabolic syndrome, and antipsychotic trials for schizophrenia.